Hetero Labs`s Generic Tolterodine Tartrate Receives Tentative Approval In US
Unichem Labs Generic Tolterodine Tartrate Receives Approval in US
Unichem Laboratories Limited has received ANDA approval for its tolterodine tartrate tablets, USP 1 mg and 2 mg from the United States Food and Drug Administration (FDA) to market a generic version of Detrol (tolterodine tartrate) tablets of Pfizer Inc.
Unique Pharm`s Generic Tolterodine Tartrate Receives Approval in US
Inventia Hlthcare’s Generic TolterodineTartrate Receives Approval In US
After the great Axovant implosion that swept away its highly touted Alzheimer’s drug, Roivant chief Vivek Ramaswamy needed one of the biotechs in his fast-growing league of drug developers to win a big Phase III trial. Based on today’s top-line release for Urovant’s Phase III urinary incontinence drug vibegron, the team is claiming that victory and prepping an application for the FDA.
Urovant Sciences said its experimental overactive bladder drug vibegron improved symptoms in a large mid-stage study, a welcome signal for the company as it evaluates the drug further in a phase III initiated earlier this year.
Hetero Labs III Generic Tolterodine Tartrate Receives Approval In US
Ivax`s (Tolterodine Tartrate 1Mg, 2Mg) Approved in USA for Overactive Bladder